Wang, X., Li, X., Qie, S., Zheng, Y., Liu, Y., & Liu, G. (2018). The efficacy and safety of once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus: A systemic review and meta-analysis. Medicine (Baltimore).
シカゴスタイル引用形Wang, Xianying, Xuejing Li, Suhui Qie, Yingying Zheng, Yang Liu, , Guoqiang Liu. "The Efficacy and Safety of Once-weekly DPP-4 Inhibitor Omarigliptin in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta-analysis." Medicine (Baltimore) 2018.
MLA引用形式Wang, Xianying, et al. "The Efficacy and Safety of Once-weekly DPP-4 Inhibitor Omarigliptin in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta-analysis." Medicine (Baltimore) 2018.
警告: この引用は必ずしも正確ではありません.